Catherine Schulte
Stock Analyst at Baird
(3.36)
# 1,005
Out of 4,667 analysts
114
Total ratings
53.49%
Success rate
13.81%
Average return
Main Sectors:
Stocks Rated by Catherine Schulte
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MTD Mettler-Toledo International | Maintains: Neutral | $1,375 → $1,310 | $1,166.90 | +12.26% | 6 | Nov 11, 2024 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Outperform | $10 → $9 | $4.82 | +86.72% | 4 | Nov 8, 2024 | |
| EXAS Exact Sciences | Maintains: Outperform | $70 → $67 | $52.70 | +27.13% | 13 | Nov 6, 2024 | |
| TECH Bio-Techne | Maintains: Outperform | $82 → $84 | $68.72 | +22.24% | 9 | Oct 31, 2024 | |
| AVTR Avantor | Maintains: Outperform | $27 → $26 | $20.14 | +29.10% | 10 | Oct 28, 2024 | |
| TMO Thermo Fisher | Maintains: Outperform | $632 → $622 | $512.84 | +21.29% | 25 | Oct 24, 2024 | |
| DHR Danaher | Maintains: Outperform | $278 → $277 | $233.10 | +18.83% | 6 | Oct 23, 2024 | |
| QGEN Qiagen | Maintains: Outperform | $49 → $52 | $42.09 | +23.54% | 2 | Aug 2, 2024 | |
| A Agilent Technologies | Maintains: Outperform | $147 → $136 | $128.57 | +5.78% | 14 | May 30, 2024 | |
| CSTL Castle Biosciences | Maintains: Outperform | $42 → $38 | $28.45 | +33.57% | 7 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $56 → $33 | $41.11 | -19.73% | 3 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $335 → $281 | $131.68 | +113.40% | 7 | Sep 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $208 → $217 | $357.77 | -39.35% | 7 | Oct 30, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $17 → $20 | $167.88 | -88.09% | 1 | Jun 28, 2018 |
Mettler-Toledo International
Nov 11, 2024
Maintains: Neutral
Price Target: $1,375 → $1,310
Current: $1,166.90
Upside: +12.26%
Maravai LifeSciences Holdings
Nov 8, 2024
Maintains: Outperform
Price Target: $10 → $9
Current: $4.82
Upside: +86.72%
Exact Sciences
Nov 6, 2024
Maintains: Outperform
Price Target: $70 → $67
Current: $52.70
Upside: +27.13%
Bio-Techne
Oct 31, 2024
Maintains: Outperform
Price Target: $82 → $84
Current: $68.72
Upside: +22.24%
Avantor
Oct 28, 2024
Maintains: Outperform
Price Target: $27 → $26
Current: $20.14
Upside: +29.10%
Thermo Fisher
Oct 24, 2024
Maintains: Outperform
Price Target: $632 → $622
Current: $512.84
Upside: +21.29%
Danaher
Oct 23, 2024
Maintains: Outperform
Price Target: $278 → $277
Current: $233.10
Upside: +18.83%
Qiagen
Aug 2, 2024
Maintains: Outperform
Price Target: $49 → $52
Current: $42.09
Upside: +23.54%
Agilent Technologies
May 30, 2024
Maintains: Outperform
Price Target: $147 → $136
Current: $128.57
Upside: +5.78%
Castle Biosciences
Mar 1, 2023
Maintains: Outperform
Price Target: $42 → $38
Current: $28.45
Upside: +33.57%
Nov 21, 2022
Maintains: Outperform
Price Target: $56 → $33
Current: $41.11
Upside: -19.73%
Sep 22, 2020
Maintains: Neutral
Price Target: $335 → $281
Current: $131.68
Upside: +113.40%
Oct 30, 2019
Maintains: Neutral
Price Target: $208 → $217
Current: $357.77
Upside: -39.35%
Jun 28, 2018
Maintains: Outperform
Price Target: $17 → $20
Current: $167.88
Upside: -88.09%